230 related articles for article (PubMed ID: 22107151)
1. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets.
Dal Col J; Mastorci K; Faè DA; Muraro E; Martorelli D; Inghirami G; Dolcetti R
Cancer Res; 2012 Apr; 72(7):1825-35. PubMed ID: 22311672
[TBL] [Abstract][Full Text] [Related]
3. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
Shukla S; Rizvi F; Raisuddin S; Kakkar P
Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
[TBL] [Abstract][Full Text] [Related]
4. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
5. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
6. mTORC2 Is the Major Second Layer Kinase Negatively Regulating FOXO3 Activity.
Jimenez L; Amenabar C; Mayoral-Varo V; Mackenzie TA; Ramos MC; Silva A; Calissi G; Grenho I; Blanco-Aparicio C; Pastor J; Megías D; Ferreira BI; Link W
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080182
[TBL] [Abstract][Full Text] [Related]
7. The role of FOXO3 in DNA damage response in thyrocytes.
Klagge A; Weidinger C; Krause K; Jessnitzer B; Gutknecht M; Fuhrer D
Endocr Relat Cancer; 2011 Oct; 18(5):555-64. PubMed ID: 21712344
[TBL] [Abstract][Full Text] [Related]
8. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
[TBL] [Abstract][Full Text] [Related]
9. A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation.
Mahajan SG; Fender AC; Meyer-Kirchrath J; Kurt M; Barth M; Sagban TA; Fischer JW; Schrör K; Hohlfeld T; Rauch BH
Thromb Haemost; 2012 Jul; 108(1):148-58. PubMed ID: 22552808
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
11. Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells.
Prasad A; Park IW; Allen H; Zhang X; Reddy MV; Boominathan R; Reddy EP; Groopman JE
Oncogene; 2009 Mar; 28(12):1518-28. PubMed ID: 19198627
[TBL] [Abstract][Full Text] [Related]
12. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.
Liang R; Rimmelé P; Bigarella CL; Yalcin S; Ghaffari S
Cell Cycle; 2016; 15(6):861-7. PubMed ID: 26929388
[TBL] [Abstract][Full Text] [Related]
13. The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells.
Kim A; Park S; Lee JE; Jang WS; Lee SJ; Kang HJ; Lee SS
Leuk Res; 2012 Jul; 36(7):912-20. PubMed ID: 22560334
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
[TBL] [Abstract][Full Text] [Related]
15. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
16. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand.
Engström M; Karlsson R; Jönsson JI
Exp Hematol; 2003 Apr; 31(4):316-23. PubMed ID: 12691919
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of CDK4/Rb and PI3K/AKT/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas.
Divakar SK; Ramana Reddy MV; Cosenza SC; Baker SJ; Perumal D; Antonelli AC; Brody J; Akula B; Parekh S; Reddy EP
Leukemia; 2016 Jan; 30(1):86-93. PubMed ID: 26174628
[TBL] [Abstract][Full Text] [Related]
19. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells.
Tsuji T; Maeda Y; Kita K; Murakami K; Saya H; Takemura H; Inaki N; Oshima M; Oshima H
Oncogene; 2021 Apr; 40(17):3072-3086. PubMed ID: 33795838
[TBL] [Abstract][Full Text] [Related]
20. FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
Weidinger C; Krause K; Mueller K; Klagge A; Fuhrer D
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1361-71. PubMed ID: 21752881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
